EUVIMEDEUVIMED entdecken
Crossref

Induced regulatory B cells stably expressing interleukin-10 reverse central nervous system autoimmunity by targeting myeloid cells

Benoît Manfroi, Van Duc Dang, Bui Thi Cuc, Annemarie Jungmann, Sibyline Borzakian, Yanli Tong, Claire Beauvineau, Louise Dupuis, Elena Guffart, Katharina Borst, Ngan Thu Nguyen, Zhiguo Wu und 24 weitere

Immunity · 2026

DOI: 10.1016/j.immuni.2026.09.006 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Immunity, 2026. Verfasst von Benoît Manfroi und 35 weiteren Autor:innen. Beteiligte Einrichtung: Université Paris Cité, INSERM U1151, CNRS UMR8253, Institut Necker Enfants Malades, 75015 Paris, France. Hauptthemen laut MEDLINE: Interleukin-10, Encephalomyelitis, Autoimmune, Experimental, B-Lymphocytes, Regulatory, Myeloid Cells. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 92 Literaturangaben. Gefördert von: AXA Research Fund, Université Sorbonne Paris Cité, Socialist Republic of Vietnam Ministry of Science and Technology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The lack of approaches to produce interleukin (IL)-10-producing B cells at high frequency has hampered mechanistic investigation into the generation, fate, and activity of these regulatory cells. We screened pharmacological compounds for their ability to induce IL-10 expression in B cells. One compound, N6, promoted stable IL-10 expression in >95% of B cells. Transfer of IL-10+ B cells induced remission of experimental autoimmune encephalomyelitis. N6-induced B cells accumulated in the central nervous system (CNS) and differentiated into IL-10+ plasma cells, promoting transcriptional and phenotypic changes in myeloid cells within the CNS. The therapeutic effect of IL-10+ B cell transfer was abrogated in mice lacking IL-10 receptor expression in long-lived myeloid cells, pointing to microglia as targets of B cell-derived IL-10. Importantly, an N6 analog corrected defective IL-10 expression in B cells from multiple sclerosis patients. Our findings establish a pharmacological strategy to generate IL-10+ B cells with therapeutic potential and identify microglia as critical targets for intercepting neuroinflammatory disease progression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Interleukin-10Encephalomyelitis, Autoimmune, ExperimentalB-Lymphocytes, RegulatoryMyeloid CellsCentral Nervous SystemAutoimmunityAnimalsMiceHumansMicrogliaMultiple SclerosisMice, Inbred C57BLMice, KnockoutFemale

Stichwörter der Autor:innen

cell therapyexperimental autoimmune encephalomyelitisimmune-mediated diseasesinduced regulatory B cellsinterleukin-10microgliamultiple sclerosisneuroinflammation

Substanzen

Interleukin-10

Autor:innen und Institutionen

  • Université Paris Cité, INSERM U1151, CNRS UMR8253, Institut Necker Enfants Malades, 75015 Paris, France.
  • Deutsches Rheuma-Forschungszentrum, A Leibniz Institute, Berlin, Germany; Department of Rheumatology and Clinical Immunology, Charité - Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt-Universität zu Be…
  • Department of Genetics/Epigenetics, Saarland University, Saarbrücken, Germany.
  • Université Paris Cité, INSERM U1151, CNRS UMR8253, Institut Necker Enfants Malades, 75015 Paris, France; CNRS UMR 9187, INSERM U1196, Chemistry and Modeling for the Biological of Cancer, Institut Curie, PSL Research Uni…
  • CNRS UMR 9187, INSERM U1196, Chemistry and Modeling for the Biological of Cancer, Institut Curie, PSL Research University, 91405, Orsay, France; CNRS UMR 9187, INSERM U1196, Chemistry and Modeling for the Biological of…
  • Institut Curie, Université PSL, Sorbonne Université, CNRS UMR168, Physics of Cells and Cancer, 75005 Paris, France.

Förderung

  • AXA Research Fund
  • Université Sorbonne Paris Cité
  • Socialist Republic of Vietnam Ministry of Science and Technology
  • Medical Research Foundation at the University Hospital Erlangen
  • French Multiple Sclerosis Foundation
  • European Research Council
  • Institut Merieux

Zitieren

APA

Manfroi, B., Dang, V. D., Cuc, B. T., Jungmann, A., Borzakian, S., Tong, Y., Beauvineau, C., Dupuis, L., Guffart, E., Borst, K., Nguyen, N. T., Wu, Z., Alvarez-Simon, D., Chyzak, G., Schäfer, S., Gerlach, R. G., Frischbutter, S., Hamann, A., Wehbe, L. S., …, & Fillatreau, S. (2026). Induced regulatory B cells stably expressing interleukin-10 reverse central nervous system autoimmunity by targeting myeloid cells. Immunity. https://doi.org/10.1016/j.immuni.2026.09.006

Vancouver

Manfroi B, Dang VD, Cuc BT, Jungmann A, Borzakian S, Tong Y, et al. Induced regulatory B cells stably expressing interleukin-10 reverse central nervous system autoimmunity by targeting myeloid cells. Immunity. 2026. doi:10.1016/j.immuni.2026.09.006

BibTeX
@article{Manfroi2026,
  author = {Manfroi, Benoît and Dang, Van Duc and Cuc, Bui Thi and Jungmann, Annemarie and Borzakian, Sibyline and Tong, Yanli and Beauvineau, Claire and Dupuis, Louise and Guffart, Elena and Borst, Katharina and Nguyen, Ngan Thu and Wu, Zhiguo and Alvarez-Simon, Daniel and Chyzak, Guillaume and Schäfer, Simon and Gerlach, Roman G and Frischbutter, Stefan and Hamann, Alf and Wehbe, Layale Salem and El Behi, Mohamed and Luka, Marine and Ménager, Mickaël and Jouneau, Luc and Boudinot, Pierre and Jung, Steffen and Winkler, Thomas H and Liblau, Roland and Marignier, Romain and Isambert, Hervé and Prinz, Marco and Amann, Lukas Simon and von Kries, Jens Peter and Specker, Edgar and Walter, Jörn and Mahuteau-Betzer, Florence and Fillatreau, Simon},
  title = {Induced regulatory B cells stably expressing interleukin-10 reverse central nervous system autoimmunity by targeting myeloid cells},
  journal = {Immunity},
  year = {2026},
  doi = {10.1016/j.immuni.2026.09.006}
}
Kostenlos starten →